Background: We examined the rate of second primary colorectal cancer (SPCRC) in a cohort of 29 471 patients first diagnosed with colorectal cancer (CRC) from 1987 to 1996, in New South Wales (NSW), Australia.
introduction
Colorectal cancer (CRC) is one of the most common cancers in the Western World with >500 000 new cases diagnosed each year. The prognosis for these patients depends mainly on the tumour stage at diagnosis. Despite the fact that more than twothirds of patients undergo surgery and often receive adjuvant therapy, a significant number of these patients will develop tumour recurrence as distant metastasis, local recurrences or second primary colorectal cancers (SPCRCs) [1] .
Reported crude rates of SPCRCs vary from 0.3% to 9%, estimated cumulative incidence from 6.3% over 18 years to 30% over 41 years of observation, and annual incidence is estimated at 0.35% per year [2] [3] [4] [5] [6] [7] [8] [9] . Standardised incidence ratios (SIRs), comparing the risk of SPCRC in those with a history of CRC with the CRC incidence in the general population, vary from 1.45 to 1.9 [4, 8] .
This observed variation in risk estimates could be influenced by various factors including the study design (retrospective versus prospective), the choice of database (cancer registry versus single centre), the length of patient follow-up, the patient population (for example, those with hereditary CRC syndromes) and finally the definition of SPCRC. Moreover, differences in surveillance strategies could also impact on the identification and estimates of SPCRC. To harmonise followup strategies for patients with a history of CRC, the American Gastroenterological Association and the American Cancer Society recently published surveillance guidelines [10, 11] . The guidelines recommend an initial full colonoscopy at the time of diagnosis, or within 3-6 months of surgery, to detect synchronous lesions and recurrent disease and that further colonoscopies should be carried out 1 year after the tumour resection and then every 3-5 years in order to detect SPCRC. However, these guidelines have not been adopted in many countries and optimal surveillance regimes are yet to be established.
The identification of patients at greatest risk of developing SPCRC has important clinical implications and could potentially lead to more targeted and intensive surveillance in particular subpopulations. Understanding how risk changes over time could also help to determine the optimum duration and frequency of surveillance. Currently, several factors have been associated with an increased risk of SPCRC including age, previous or synchronous adenomas or history of CRC, right-sided index tumours and microsatellite instability (MSI) [5-9, 12, 13] .
In this study, we have examined factors associated with an increased risk of developing SPCRC within a large populationbased cancer registry.
methods
Data from 31 752 individuals aged ‡30 years with a first occurrence of a primary CRC, from1987 to 1996 and followed up to 2004, were obtained from the New South Wales (NSW) Central Cancer Registry (CCR), a population-based cancer registry covering a population of >6 million individuals in Australia. Notification of cancer is a statutory requirement for all NSW public and private hospitals, radiotherapy departments, nursing homes, pathology departments and outpatient departments [14] . The CCR has high standards of data completeness, quality and follow-up; the data are accepted by the International Agency for Research on Cancer for publication in Cancer Incidence in Five Continents [15] .
In line with a report by Shureiqi et al. [8] and the SPCRC definition by McCredie et al. [16] , a SPCRC was defined as a new colorectal primary diagnosed at least 2 months after the diagnosis of the first CRC. Time from diagnosis of first to SPCRC was calculated, and cumulative and annual incidence of SPCRCs, overall and by sex and age group at first diagnosis, were analysed using Kaplan-Meier methods (Stata IC version 10.0; StataCorp, College Station, TX), accounting for the number of individuals at risk over the 18-year observation period.
We excluded patients <30 years of age at diagnosis of first primary to avoid a major bias towards selection of patients with inherited CRC syndromes such as familial adenomatous polyposis or hereditary non-polyposis colon cancer which have been associated with an increased risk of SPCRC.
Sex, 5-year age group, date of diagnosis, site of first and second diagnoses of primary CRCs and date of death, where applicable, were provided. In all, 2281 patients (7.2%) died within 2 months of first diagnosis and were excluded from further analyses. Of the remaining 29 471 patients, 55% were male, 75% were aged ‡60 years and 66% had first primaries of the colon ( Table 1) .
The number of SPCRCs that would be expected to occur based on cancer incidence in the corresponding general population over the same period was calculated and compared with the observed number of SPCRCs.
Person-years at risk were calculated from 2 months after the date of diagnosis of the first primary to diagnosis of a SPCRC, death or the end of the observation period, 31 December 2004, whichever occurred first. Person-years at risk for each individual were partitioned into 5-year age categories and calendar years. Changes in risk associated with age and time period were taken into account.
The incidence of first occurrences of CRC in the NSW general population from 1987 to 2004 was calculated from the numbers of primary tumours recorded in the CCR. In 2004, the standardised incidence rates per 100 000 population for CRC in NSW was 63.9. For men, the incidence was 47.7 for International Classification of Diseases-10 code C18 (colon), 29.1 for code C19-21 (rectum) and 76.9 for code C18-21 (rectum). The respective figures for women were 37.8, 15.1 and 52.9.
Rates were obtained by sex, 5-year age group and calendar year. These rates were then applied to the person-years at risk of those with first primary CRC to determine the expected number of SPCRCs. Overall and age-specific risks of SPCRCs by sex were expressed as SIRs, calculated as the ratio of the observed number of SPCRCs to the expected SPCRCs. SIRs were also calculated based on site of first primary, year of diagnosis of the index primary and years from first diagnosis. The excess absolute risk (EAR) per 100 000 person-years was calculated by subtracting the expected number of cases from the observed, dividing by the person-years at risk and multiplying by 100 000.
Right-sided cancers of the colon were classified as those in the caecum (C180) through to the splenic flexure of the colon (C185). Cancers of the rectosigmoid junction (C199) were grouped together with those of the descending colon (C186) and sigmoid colon (C187) and classified as leftsided. Of those with right-sided first primaries, 52% were female. Fiftyseven per cent of those with left-sided cancers and 62% of those with first primaries of the rectum were male. Patients with primary 'overlapping colon cancers' (C188) and 'colon cancer not otherwise specified' (C189) were separated from right-or left-sided tumours in the analysis.
results incidence of SPCRCs
SPCRCs were identified in 660 patients (2.2%), during a median follow-up of 5.1 years (interquartile range 1.4-10.7 years) with a median of 3.7 years between the diagnoses of first and second primaries. SPCRCs occurred in 2.9% of those with right-sided first primaries, 2.4% of those with left-sided primaries and 1.6% of those with first primaries of the rectum. Twenty patients had multiple second primaries and 28 patients developed a third primary CRC. Thirty-two per cent of SPCRCs were identified within 2 years of the first primary CRC, and Annals of Oncology original article a total of 44% of patients were diagnosed within the first 3 years. Diagnosis of SPCRCs occurred up to 17 years after the first primary CRC, with 38% of observed SPCRCs identified ‡5 years after first diagnosis. At 5 years from first diagnosis, the overall cumulative incidence of a SPCRC was 2.1% [95% confidence interval (CI) 1.9% to 2.3%], ranging from 1.2% (95% CI 0.7% to 1.9%) in patients aged 40-49 years at first diagnosis to 2.6% (95% CI 2.0% to 3.4%) in patients ‡80 years. At 18 years from first diagnosis, the overall cumulative incidence was 5.5% (95% CI 4.9% to 6.3%) (Figure 1 ), corresponding to an average annual incidence of 0.36%.
SIRs by sex and age at diagnosis of first primary
The rate of SPCRC in patients with a previous history of CRC was greater than the CRC incidence in the corresponding general population (SIR = 1.5, 95% CI 1.4-1.6). For both sexes, the comparative risk was greatest in those individuals who presented with a first diagnosis of CRC aged <60 years (SIR >2) ( Table 2 ). In accordance with rates of CRC in the general population, rates of SPCRCs were generally higher in males compared with females (401 versus 273 per 100 000 personyears), although rates of SPCRCs in patients aged 50-59 and 60-69 years at first diagnosis were similar for both males and females (330 and 380 per 100 000 person-years) (Table 3) . Thus, females aged 50-69 years were at greater risk than males of the same age, when compared with the corresponding general population. The overall EARs were generally higher in females which was related to the considerably higher EARs in those patients' groups of 50-59 and 60-69 years ( Table 2 ).
SIRs by site of first primary
Comparative risks were greater for those with a right-sided first primary of the colon compared with those with left-sided or rectal (Table 4 ). These differences by site of first primary were seen in males and in most age groups. However, regardless of site of first primary, SIRs were increased for those aged 30-49 years at first diagnosis (SIRs >4.6). Those with right-sided first primaries were at increased risk of right-sided (SIR = 2.0, 95% CI 1.6-2.4), left-sided (SIR = 2.2, 95% CI 1.8-2.7) and rectal cancers (SIR = 1.6, 95% CI 1.2-2.1), while those with left-sided or rectal first primaries were at increased risk for developing right-sided colon cancers only (SIR = 2.5, 95% CI 2.1-2.9 and SIR = 2.2, 95% CI 1.7-2.7, respectively). Due to the small number of patients with overlapping colon cancers (C188) and the heterogeneous group of patients with colon cancer not otherwise specified (C189), a detailed SIR analysis by site of first primary was not carried out in these two groups. SIRs by time from diagnosis of first primary
Increased risk was greatest in the initial 5 years after first diagnosis, approaching levels prevailing in the general population after 5 years (Table 2) . However, increased risk persisted up to 10 years after the first primary diagnosis in females, in patients with right-sided index cancers and those <60 years at first diagnosis (Tables 2 and 4 , Figure 2 ). Increased risks of right-sided colon cancer were seen beyond 10 years from the first primary CRC (SIR = 1.5, 95% CI 1.1-2.1). No differences in SIRs were seen by year of first diagnosis or observation.
discussion
The increased risk of developing SPCRC after primary tumour resection has been recognised and various studies have tried to identify risk factors which potentially could guide clinicians to choose an appropriate and tailored postoperative surveillance strategy for patients with CRC. However, some of these studies have been criticised for their small patient numbers, single institution character, short follow-up periods and heterogeneous definitions of SPCRC. In this retrospective analysis, based on the large and comprehensive NSW CCR database, we could demonstrate that patients with a history of CRC were at increased risk of developing SPCRC, especially during the first 5 years after initial diagnosis. In our population, the cumulative incidence of SPCRC was increased at 5.5% during the 18-year period and similar to other studies which reported a cumulative incidence of 6.3% at 18 years and 7.2% at 20 years [4, 9] . Additionally, the risk of developing a SPCRC was 1.5 times higher in patients with a history of CRC compared with the risk of a first CRC in the general population and in accordance with published reports [8, 9] . We also confirmed an inverse relationship between the SIRs and age groups at first diagnosis similar to the results by Shureiqi et al. [8] , although our estimates of SIRs in younger patients were somewhat more modest (i.e. a SIR of 23 versus 47 for patients aged 30-39 years).
Consistent with the current literature, we found that the risk of SPCRC compared with CRC rates in the general population was elevated up to 5 years after first diagnosis of CRC. However, an important and new finding in our study was that this risk remained increased up to 10 years in females, in patients with right-sided index cancers and in patients <60 years at first diagnosis. These interesting results may be an indication for increased surveillance beyond that of the corresponding general population. Additionally, given the underlying rates of SPCRC incidence and EARs of 226 and 183 per 100 000 person-years in females in the two age groups of 
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50-59 and 60-69 years, respectively, it may be particularly beneficial for females in these age groups at first CRC diagnosis to be targeted for more intensive surveillance.
Another important finding of our study was that patients with an initial right-sided CRC had a twofold risk of a second right-sided primary compared with the general population. In contrast, in patients with initial left-sided or rectal cancers, the risk of developing SPCRC in these areas was equivalent or even less compared with the general population. However, rates of new right-sided colon cancers were also increased by twofold in these two groups. Interestingly, despite having undergone tumour resection of the right colon, these findings may indirectly reflect the use of historical surgical approaches. In the era of modern surgical practice, most cases with right-sided colon cancer would have been operated with a total right-sided hemicolectomies without leaving any right-sided colon.
A major limitation of our retrospective study was the inability to examine surveillance patterns in relation to SPCRC identification. Additionally, changes of existing and implementation of new surveillance guidelines over time could have resulted in changes of the follow-up pattern and removal of precancerous polyps and subsequently in SPCRC detection. However, we could not demonstrate any differences in SPCRC rates by the year of first diagnosis, indicating that a similar surveillance strategy was adopted throughout our study period.
Another important factor which has not been evaluated in this population-based cohort is the use of novel biomarkers. There is an increasing body of clinical evidence that biological markers such as MSI may predict the development of SPCRCs. A study by Shitoh et al. [7] investigated the role of MSI status in 328 patients who underwent regular colonoscopies for up to 3 years after curative resection of their primary CRC. After a median follow-up time of 74 months, the incidence of SPCRC was significantly higher in patients with MSI-positive tumours compared with MSI-negative tumours (15.3% versus 3%; P < 0.01). The cumulative 5-year incidence of SPCRC was also significantly higher in MSI-positive cases compared with MSI-negative cases (12.5% versus 2.5%; P < 0.0001). Multivariate analysis demonstrated that MSI and coexistence of adenoma were independent risk factors for the occurrence of SPCRC and the authors concluded that in the presence of both factors, a stringent surveillance strategy should be adopted.
In conclusion, we identified three new subgroups of patients with a history of CRC who are at an increased risk of developing SPCRC. The adoption of accepted surveillance guidelines for patients with a history of CRC and the incorporation of additional risk factors could be a major step forward to improve and tailor surveillance strategies for patients who are at risk to develop SPCRC. This approach may help to detect precancerous lesions early and subsequently decrease the incidence of SPCRC. While there is evidence to indicate an overall survival benefit at 5 years for patients undergoing more intensive follow-up [17] , the assumption that more intensive surveillance will lead to early detection resulting in improved patient outcomes in the longer term is yet to be proven. Large prospective trials that are currently underway, such as the 'Gruppo Italiano di Lavoro per la Diagnosi Anticipata' [18] , the 'Follow-up After Colorectal Surgery' [19] trial and the 'Colorectal Cancer Follow-up Study' [20] , should contribute substantially to this body of evidence. Finally, the use of novel biomarkers such as MSI status should also be considered and incorporated in prospective studies to help identify SPCRC. 
